All lobbying filings
W STRATEGIES, LLC
Lobbying for SUPERNUS PHARMACEUTICALS FKA SAGE THERAPEUTICS · A clinical-stage biopharmaceutical company.
Filing
2nd Quarter - Report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 18, 2025
Income
$50,000.00
What the client paid this registrant for the period.
Client based in
Massachusetts
Lobbying activity
1
Education and awareness of mental health issues especially as it relates to access for postpartum depression treatment and major depressive disorder.